Evidence map›Paper›PMID 31752824›Full record

ArticleBMC complementary and alternative medicine2019

Cytotoxic activity of crude extracts from Datura stramonium's fungal endophytes against A549 lung carcinoma and UMG87 glioblastoma cell lines and LC-QTOF-MS/MS based metabolite profiling.

Kudzanai Ian Tapfuma, Nkemdinma Uche-Okereafor, Tendani Edith Sebola, Raeesa Hussan, Lukhanyo Mekuto, Maya Mellisa Makatini, Ezekiel Green, Vuyo Mavumengwana

Abstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. EndophyticInternational journal of molecular sciences · 2024
    Article
  7. Penicillides fromMolecules (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Cytotoxic Potential of Bioactive Compounds fromMolecules (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kudzanai Ian TapfumaDepartment of Biotechnology and Food Technology, Faculty of Science, University of Johannesburg, Box 17011, Doornfontein, Johannesburg, PO, 2028, South Africa.
Nkemdinma Uche-OkereaforDepartment of Biotechnology and Food Technology, Faculty of Science, University of Johannesburg, Box 17011, Doornfontein, Johannesburg, PO, 2028, South Africa.
Tendani Edith SebolaDepartment of Biotechnology and Food Technology, Faculty of Science, University of Johannesburg, Box 17011, Doornfontein, Johannesburg, PO, 2028, South Africa.
Raeesa HussanSouth African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Tygerberg, 7505, South Africa.
Lukhanyo MekutoDepartment of Chemical Engineering, Faculty of Engineering and the Built Environment, University of Johannesburg, Box 17011, Doornfontein, Johannesburg, PO, 2028, South Africa.
Maya Mellisa MakatiniMolecular Sciences Institute, School of Chemistry, University of the Witwatersrand, P.O Box Wits, Johannesburg, 2050, South Africa.
Ezekiel GreenDepartment of Biotechnology and Food Technology, Faculty of Science, University of Johannesburg, Box 17011, Doornfontein, Johannesburg, PO, 2028, South Africa.
Vuyo MavumengwanaSouth African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Tygerberg, 7505, South Africa. vuyom@sun.ac.za.ORCID http://orcid.org/0000-0003-4672-6176

Funding

South African National Research Foundation AWARESouth African National Research Foundation TTK150612119319South African National Research Foundation TTK150713125714
6 · The paper itself

Abstract

backgroundEndophytic fungi are a proven source of bioactive secondary metabolites that may provide lead compounds for novel drug discovery. In this study, crude extracts from fungal endophytes isolated from Datura stramonium were evaluated for cytotoxic activity on two human cancer cell lines.

methodsFungal endophytes were isolated from surface sterilized aerial parts of D. stramonium and identified using molecular, morphological and phylogenetic methods. Ethyl acetate crude extracts from these isolates were evaluated for cytotoxic activity on A549 lung carcinoma and UMG87 glioblastoma cell lines. Metabolite profiling was then performed by liquid chromatography coupled to quadrupole time-of-flight with tandem mass spectrometry (LC-QTOF-MS/MS) for the cytotoxic crude extract.

resultsEleven fungal endophytes were identified from D. stramonium. Significant cytotoxicity was only observed from the crude extract of Alternaria sp. KTDL7 on UMG87 glioblastoma cells (IC

conclusionThe findings in this study suggest that the crude extract of Alternaria sp. KTDL7 possesses compound(s) cytotoxic to glioblastoma multiforme cells. Future studies to isolate and characterize the cytotoxic compound(s) from this fungus could result in lead development of a fungal-based drug for glioblastoma multiforme treatment.

Indexed as

A549 CellsAntineoplastic AgentsBiological ProductsCell Line, TumorCell SurvivalChromatography, LiquidDatura stramoniumEndophytesFungiHumansTandem Mass SpectrometryAntineoplastic AgentsBiological ProductsCytotoxicityDatura stramoniumEndophytesGlioblastomaLung carcinomaSecondary metabolites

Identifiers

PMID31752824
PMCPMC6873518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.